Brazil Vaccine Industry Outlook 2024 - 2028

See how Brazil Vaccine performed compared to key markets.

Key Market Indicators

Brazil's vaccination coverage for children aged one year is projected to decline to 78% by 2028, down from 81% in 2023. This represents an average annual decrease of 0.5 percentage points. Historically, since 1985, the country's vaccination coverage has been decreasing by an average of one percentage point per year. Meanwhile, Brazilian vaccine exports are forecasted to drop slightly. By 2028, exports are expected to reach approximately $14.77 million, down from $14.90 million in 2023, reflecting an annual decline of 0.3% in compounded annual growth rate (CAGR). Despite this recent downturn, Brazilian vaccine supply had grown by 1.9% annually since 1994. In 2023, Brazil ranked 28th in the world for vaccine exports, with the Czech Republic taking the lead at $14.90 million. Belgium, the United Kingdom, and France occupied the second, third, and fourth spots, respectively. On the import front, Brazil's vaccine imports are anticipated to rise. By 2028, imports are set to reach approximately $807.46 million, up from $738.41 million in 2023, marking an annual growth rate of 1.3% in CAGR. Since 1994, the nation's demand for vaccines has increased by 2.6% annually.

Brazil Vaccine Market Data and Forecasts

Brazil Vaccine : how will it grow in the coming years?

Forecast: Diphtheria Tetanus Toxoid and Pertussis Third Dose (DTP3) Immunization Coverage in Brazil
Forecast: Diphtheria Tetanus Toxoid and Pertussis Third Dose (DTP3) Immunization Coverage in Brazil
Forecast: Polio Vaccine Third Dose (Pol3) Immunization Coverage in Brazil
Forecast: Baccille Calmette Guérin Vaccine (BCG) Immunization Coverage in Brazil
Forecast: Import of Vaccines for Human Use to Brazil
Forecast: Export of Vaccines for Human Use from Brazil
View More

Other Top Countries about Vaccine